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Preface
Multipotent blood progenitor cells enter the thymus and begin a protracted differentiation process
in which they gradually acquire T-cell characteristics while shedding their legacy of
developmental plasticity. Notch signalling and basic helix-loop-helix E-protein transcription
factors collaborate repeatedly to trigger and sustain this process throughout the period leading up
to T-cell lineage commitment. Nevertheless, the process is discontinuous with separately regulated
steps that demand roles for additional collaborating factors. This review discusses new evidence
on the coordination of specification and commitment in the early T-cell pathway; effects of
microenvironmental signals; the inheritance of stem-cell regulatory factors; and the ensemble of
transcription factors that modulate the effects of Notch and E proteins, to distinguish individual
stages and to polarize T-lineage fate determination.
Mammalian T cells of diverse functional types share a complex developmental history. They
originate from pluripotent precursors in the bone marrow or fetal liver, which migrate to the
thymus, the sole function of which is to initiate and sustain T-cell differentiation. Relatively
few T-cell progenitors migrate into the thymus per day, but they respond to this new
environment by proliferating extensively, while initiating the T-cell differentiation
transcriptional programme1–4, and gradually turning off genes that allow differentiation to
non-T-cell lineages. They then undergo T-cell receptor (TCR) gene rearrangements and
assemble TCR complexes, upon which their future survival and functions will depend.
These cells can mature into different T-cell lineages, including γδ T cells and αβ T cells. The
αβ T cells diverge further into different sublineages such as CD4+ T cells, CD8+ T cells and
NKT cells as well as regulatory T cells (Treg), each with greatly differing functions once
they emigrate from the thymus to the periphery. However, these diverse T-cell lineages
share their early developmental history, and many of the key genes required in later T-cell
functions are first expressed prior to TCR rearrangement. As the regulatory mechanisms that
guide stem cells into the T-cell lineage become increasingly well-defined, a sequence of
events is revealed that may make early T-cell development a particularly illuminating
paradigm for stem-cell-based modes of development in general.
The T-lineage commitment process consists of an irreversible progression of distinct
developmental stages. Each of these stages has the potential to be sustained over multiple
cell cycles. This implies that particular regulatory changes, perhaps environmentally
triggered, must intervene to advance the cells from one state to the next. Clear changes in
gene expression and developmental potential mark these transitions. Yet genetic evidence,
from germline and conditional knockouts, emphasizes the requirements for a stable core
group of transcription factors that act repeatedly at successive stages. In this Review, we
explore how this image of regulatory persistence can be modified to explain an outcome of
dramatic and irreversible developmental change.
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Landmarks for early T-cell development
We first review what happens in T-cell specification, before considering why it happens.
From fetal through adult life, T-cell precursors develop through distinct stages defined by
multiparameter flow cytometry1,5–8. In mice, cell-transfer experiments in vivo, as well as
clonal-cell- culture experiments in vitro, have revealed at which stages these cells lose the
non-T-lineage developmental potential inherited from their stem-cell progenitors and when
they gain specific T-lineage characteristics9–13. The exact types of precursor cells that can
participate, the branch points, the alternative pathways, and the kinetics of T-cell
development are increasingly well-defined in mice1,8,9,14,15 and humans7,16. This evidence,
spanning contributions of many groups for at least two decades, is summarized for the
murine case in Fig. 1, Table 1, and Box 1.
Curiously, several distinct progenitor types can enter the T-cell pathway9,15. But one major
progenitor source in adult mice consists of lympho-myeloid pluripotent precursors (LMPPs)
in the bone marrow or blood, which can give rise to macrophages, dendritic cells (DCs),
natural killer (NK) cells, B cells and T cells, but not erythrocytes or megakaryocytes17,18.
The earliest human thymic precursors also have lymphoid and myeloid potential19,20.
Within the murine LMPP population, cells with the capacity to migrate to the thymus are
probably distinguished by expression of the CC chemokine receptor 9 (CCR9), in addition
to the stem- and progenitor-cell markers cKIT (also known as CD117), stem-cell antigen 1
(SCA1), and the growth-factor-receptor tyrosine kinase FLT3 (also called FLK2), which
define LMPPs9,21,22. Prethymic cells in the fetal blood and liver might have somewhat
different properties from postnatal thymus-seeding cells23,24.
Development through the first “pro-T cell” stages, from early T precursor (ETP) to double
negative 3 (DN3), is TCR independent and is coordinated with migration through distinct
thymic microenvironments8 (Fig. 1). In ETP and DN2 stages, cells proliferate extensively
while acquiring their first T-cell characteristics. Although precursors may actually initiate
TCR (or immunoglobulin heavy chain) gene rearrangements abortively, some even before
reaching the thymus25,26, none of these have the full V(D)J rearrangement required to
permit expression of TCRβ, TCRγ, and/or TCRδ genes. As the cells reach the DN3 stage,
they stop proliferating, greatly increase TCR gene rearrangement, and generate the first fully
rearranged TCR loci. DN3 cells that succeed in making in-frame TCR gene rearrangements
become activated by TCR-dependent selection (DN3b cells); this distinguishes them from
DN3 cells that are not yet selected (DN3a cells)27. Expression of a TCRβ chain qualifies the
cells to undergo β-selection, turning on expression of CD4 and CD8 to become double
positive (DP) cells, and eventually acquiring cell-surface TCRαβ complexes. This prepares
them for positive selection and negative selection to generate mature CD4+ or CD8+
TCRαβ+ T cells. Alternatively, DN3 cells that successfully rearrange TCRγ and δ chains
instead of β chains are selected as γδ T cells.
The thymic epithelium provides a particularly potent combination of receptor ligands and
growth factors to trigger and support pro-T-cell differentiation, proliferation and
survival8,11,15,28. The most important of the environmental inputs for T-cell development
are ligands for the Notch cell-surface receptors, specifically Delta-family ligands, Delta-like
1(DL1) and DL429. Notch signalling initiates and sustains the T-lineage programme
throughout the pro-T-cell stages, and presentation of Notch ligands by stromal cells is the
key element in successful tissue culture systems that support early T-cell development in
vitro30. In addition, the thymic epithelium produces ligands for other signalling pathways
and cytokines, such as the KIT ligand stem cell factor (SCF) and interleukin-7 (IL-7), both
of which are critical for sustaining the proliferation that pro-T cells undergo at defined
stages. Migration of the pro-T cells through different zones of the thymus may provide
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changing microenvironmental signals that help to drive T-cell differentiation programming8.
Furthermore, more mature thymic T cells can themselves have direct or indirect feedback
effects on the gene expression and differentiation of early T cells2,31.
Key transitions in programming for T-cell identity
Programming for T-lineage identity includes both specification, which confers T cell-
specific functions, and commitment, or loss of the ability to adopt alternative developmental
fates.
The cells gain T-cell characteristics not coordinately, but in a multistep cascade. Fig. 2a
depicts these gene expression changes on a color-coded logarithmic scale (>5000-fold
range), because, although relatively modest changes in gene expression can be functional,
the T-cell specification process also includes changes of much greater magnitude. T-cell
identity genes, as well as the transcription factors that regulate their expression, are turned
on in a precise order. The T-cell identity genes encode products that are critical for TCR
rearrangement [recombination activating gene 1 (RAG1) and RAG2], TCR complex
assembly (such as the CD3 chains), and signalling components, including kinases,
phosphatases and adaptor proteins such as LCK, ZAP70 (TCRζ-associated protein 70 kd),
and LAT (linker of activated T cells). There is little activation of these genes in precursors
before they enter the thymus (although there are some possible exceptions26,32), and within
the thymus, ETPs express relatively few T-cell identity genes, mostly at low levels. Most of
these genes begin to be upregulated in the DN2 stage, as Fig. 2a shows for Cd3g, Cd3e,
Zap70 and Il7ra (CD127)27,33–38 (M.A.Y. unpublished observations). Finally, by the DN3a
stage of T-cell development, T-lineage identity is set. Germline transcription of the TCRβ
variable-region gene segments is also upregulated39 as VDJ rearrangement of TCRβ genes
proceeds27. Even effector genes like IL2 become accessible for induction40. The cells are
still far from mature T cells, but they have completed assembly of the whole TCR signalling
apparatus that is necessary for β- or γδ-selection, as well as for positive and negative
selection and mature cell functions thereafter.
Concurrently, there are staged shifts in growth factor receptor expression (Fig. 2a). cKIT
expression is essential in the earliest precursors41, then gradually downregulated through the
DN3 stage37, whereas IL7Rα, which sustains most pro-T-cell proliferation42, is strongly
expressed in DN2 and DN3 stages until after β-selection. Meanwhile, IL2Rβ, an important
growth factor receptor for NK cells and mature T cells, is downregulated in a mirror
opposite pattern to that of IL7Rα (Fig. 2a). This downregulation is functionally significant
because IL2Rβ, although related to IL7Rα, transmits different signals that can divert
immature thymocytes from the T-cell lineage to the myeloid lineage43.
Commitment also occurs in discrete steps. In adult mice, whereas some thymus-seeding
progenitors initially retain B-lineage developmental potential, all rapidly lose this capability
once inside the thymus, as FLT3 and CCR9 are downregulated44,45. T-cell precursors that
populate the fetal thymus appear to have lost B-cell potential before entering the
thymus11,12. Nevertheless, both adult and fetal thymic immigrants retain DC and NK-cell
potentials until a later stage36,46–49, and at least some have macrophage and/or mast-cell
potential as well36,50 (Fig. 1). Both ETPs and many DN2 cells show readily detectable NK-
cell and DC potential if they are removed from the thymus and cultured in permissive
conditions. However, by the time the cells reach the DN3 stage, they are committed to the T-
cell lineage and can no longer develop into alternative cell types under any of these
conditions (reviewed in ref.51).
Individual ETPs can embark on these alternative pathways somewhat more easily than DN2
cells can47,52. Until recently, the graded reduction in DC and NK-cell developmental
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potential at the DN2 stage could be interpreted stochastically, with DN2 cells simply
becoming less likely to access their non-T-cell options than ETP. However, recent
evidence33 shows a discrete transition in the midst of the DN2 stage, while the cells are still
proliferating and before extensive TCRβ rearrangement. Activation of a green fluorescent
protein transgene driven by the proximal Lck promoter proves to distinguish late from early
DN2. At this point, cells specifically lose the ability to adopt the DC fate33 (Fig. 1). This
transition seems likely to be correlated with the first slight reduction in expression of cKIT
on nontransgenic DN2 cells that we will term the transition from DN2a to DN2b6 (Fig. 3).
The discovery of this transition33 shows that the potential to develop into at least three
different T-lineage alternatives – B-cell, DC, and NK-cell – may each be relinquished at
successive stages. Commitment is not a single event, but a cascade of separate
developmental renunciations that only ends at the DN3 stage when all non-T-cell options
have been lost.
Loss of DC potential appears to be coupled with a discrete regulatory event that unleashes
the full T-cell differentiation programme33, a coupling much tighter than was previously
evident. Only a few of the T-cell-identity genes are upregulated by the DN2a stage (Fig. 2c).
The earliest-responding genes are not differentiation genes but encode the transcription
factors HEBalt (HeLa E-box binding factor, alternative form) and BCL11b (B-cell
lymphoma 11b)53, discussed below. Some genes that play key roles in β-selection [Ptcra
(preTCRα), and Rag1] are strongly upregulated only at the DN2b stage or at the DN2b to
DN3a transition27,32,34,36,37 (Fig. 2c). The question is therefore what changes in
transcription factor and signalling activities (jointly termed T-lineage regulatory factors) can
explain these abrupt changes in gene expression and behavior.
T-lineage regulatory factors: core group
As shown in Fig. 2b,c, there are indeed major changes in transcription factor expression
during the progression of T-cell precursors from ETP to DN3 stages. This is evident for the
specific transcription factors chosen for presentation in Fig. 2b, which include most of the T-
cell factors known to be essential (as indicated by the stars in Fig.2), as well as most factors
implicated in lineage plasticity, those implicated in the regulation of TCR and other T-
lineage gene expression, and their closest relatives.
Notch signalling is the best-studied T-lineage positive regulator. Upon triggering, the Notch
intracellular domain (NotchIC) converts the RBPJ transcription factor (recombination site
binding protein J, also known as CSL, core binding factor/suppressor of hairless/Lag-1)
from a default repressor to an activator (reviewed in 29,54). Several T-lineage genes are
directly activated by the Notch-RBPJ complex, including distinguishing markers for the
DN2 and DN3 stages such as Ptcra and the DN2–DN3-specific marker Cd25 55–57. Another
direct Notch target gene encodes the transcription factor HES1 (hairy, enhancer of split 1).
NotchIC is the only regulator known to be able to drive ectopic T-cell development when
overexpressed. However, Notch signalling alone is not sufficient to activate or sustain the T-
cell programme.
Genetic evidence emphasizes the roles of a “core group” of diverse transcription factors or
transcription factor families that must work with Notch in the T-cell specification process,
either during or before the intrathymic T-cell precursor stages (Table 2)2,58–60. This core
group of factors includes: GATA3 (GATA sequence-binding factor 3)61; MYB
(myeloblastosis proto-oncogene); RUNX–CBFβ (runt domain or acute myelogenous
leukemia factor – core binding factor β) complexes; basic helix-loop-helix E proteins62 such
as E2A (Tcfe2a) and HEB (Tcf12); (TCF-1 (T-cell factor 1, encoded by Tcf7); the zinc-
finger repressor Growth factor independence 1 (GFI1); and Ikaros family members (Table 2;
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Fig. 2, red and orange stars). These factors are discussed extensively in the following
sections, as their roles are not only essential but are also recurrent in T-cell development.
Most of these have expression patterns consistent with persistent roles throughout the ETP
to DN3 stages (Fig. 2): they are already expressed relatively well at the ETP stage and are
upregulated only modestly compared to many other pro-T cell genes. However, the
continuous expression of these core genes cannot explain the discontinuities in
differentiation gene expression.
Stage-specific T-cell transcription factors
T-cell development also depends on factors that do not have sustained roles. Of these, the
best-studied is the ETS (E26-transformation specific) family factor PU.1 (Fig. 2, blue star),
another “core group” member, but with a difference. While it is vital for prethymic
precursor development, PU.1 switches to a T-lineage antagonist once cells progress to the
DN2a/b stages, and it must then be silenced. As described below, PU.1 is one of a cohort of
prethymically inherited factors (Fig. 2, SCL [stem cell leukemia, or TAL1], GATA2, and C/
EBPα [CCAAT-enhancer binding protein α]) that most likely sustain the lineage plasticity
of cells in early stages of T-cell development. All of these factors are downregulated to
essentially undetectable levels before β- or γδ-selection (Fig. 2b,c) and the downregulation
of these non-T factors is strongly correlated with the activation of the T-cell gene expression
programme.
Not all transcription factors inherited from haematopoietic stem cells are turned off during
T-cell specification. Many of the core group factors have important prethymic roles as well.
There is also a large set of transcription factor genes that continue to be expressed stably in
multipotent progenitors all the way to cells undergoing β-selection53. But only a few
transcription-factor genes are specifically turned on at a time that might contribute to the
onset of T-lineage gene expression in the DN2 stage. These include the zinc finger
transcription factor and tumor suppressor factor BCL11B63, a particular promoter use
isoform of the E protein HEB called HEBalt53,64, and more transiently, a transcription factor
involved in the Hedgehog signalling pathway, GLI265.
To explain the further increase in T-cell gene expression at the DN3 stage, several additional
factors need to be considered, which have been implicated through direct studies of the
regulatory elements of TCR and other T-cell genes (reviewed in 2). ETS-family and zinc-
finger factors are prominent, especially ETS1, which works in an intimate collaboration with
RUNX1-CBFβ 66,67. Both ETS1 and ETS2 are included in a group of transcription-factor
genes that are strongly upregulated at the DN2 to DN3 transition (Fig. 2b), along with
TCF-1 relative LEF-1 (lymphocyte enhancer factor 1)34. The DN3 stage is also
distinguished by peak levels of expression of the PU.1-related factor SPIB and the Notch-
RBPJ target HES1, which are shut off after β-selection. An additional high mobility group
factor, SOX13, has recently been shown to have a specific, essential role for the generation
of TCRγδ cells68; however, SOX13 is expressed throughout the pro-T cell stages, and is
only downregulated in cells that take the αβ pathway.
Thus, although Notch signalling occurs throughout, the transcription factor profile of the
cells through the ETP to DN3 stages consists of several distinct layers. On a background of
factors inherited from prethymic progenitor cells53, there is maintenance or a gradual
increase in expression of the core group factors; there is a staggered decline of factors that
could otherwise drive the cells to alternative fates; and there are new sets of factors abruptly
adding to the mixture at two precisely timed transitions, first to signal entry to the DN2
stage, and then as the cells reach the climax of cell-type specification and commitment in the
DN3 stage. Although not well studied yet, these last groups of factors are not simply stage
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markers. Notch and the core group transcription factors have different effects on early T-cell
precursors at different stages, because the ways transcription factors actually work in
development (Box 2) depend on their dose, their precise splice isoforms, their position in a
gene network, and their combinatorial interactions with other factors. It is likely that more
dynamically regulated factors, collaborating with the core group, provide this stage
specificity. The next sections focus in depth on how such interactions may operate at four
pivotal transitions in T-cell specification.
Competence to turn on the T-cell programme
Notch signalling is vital to initiate T-cell development, but it is not sufficient to activate T-
lineage genes directly69. The immediate impacts of Notch signals have been greatly clarified
by culture systems that present Notch ligands DL1 or DL4 to haematopoietic precursors on
OP9 (or other) stromal cells, thus triggering a synchronized cascade of Notch
responses35,70–74. Within several days of culture with OP9-DL1 cells and supportive
cytokines, Thy1+ CD25+ DN2 cells and ultimately DP cells can be generated from various
types of haematopoietic precursors, through a reproducible molecular pathway35,53,70,71,73.
Although Notch signalling turns on tissue-nonspecific genes such as Hes1 and Nrarp in
many cells within the population, expression of the key T-cell transcription factors GATA3
and TCF-1 is only induced within a subset of these precursors. A smaller subset of these
then proceed to a DN2-like state, turning on CD25, Thy1, CD3ε, preTCRα, and
BCL11b35,53. Because only select types of haematopoietic precursor activate these T-cell
genes in response to Notch, it is clear that additional factors are needed35.
At least four transcription factor contributions now appear to be required to enable
progenitors to undergo the T-lineage initiation response: PU.175,76; Ikaros18; RUNX family
factors, working with CBFβ 77 (Y. Guo, I. Maillard, and N. A. Speck, personal
communication); and E protein activity, from E2A and possibly its relatives such as HEB. E
proteins are already expressed in haematopoietic precursors but are engaged to unknown
extents in complexes with Id proteins or SCL (TAL1), which sequester them from activating
T-lineage specific genes. In a multipotent haematopoietic progenitor cell line, E2A levels
positively regulate some Notch target and T-lineage genes including Notch1 itself, with
synergistic effects of E2A and Notch signalling together78. This is the first of multiple
stages at which E proteins and Notch work together in early T-cell development (Fig. 4).
Competence to undergo the T-lineage response to Notch signals is under negative as well as
positive regulation in haematopoietic precursors. One newly defined mechanism is mediated
by a transcriptional repressor, LRF (leukaemia/lymphoma related factor, also known as
Zbtb7a or Pokémon). LRF makes B-cell development possible by counteracting Notch
responsiveness in prethymic haematopoietic precursors79. It limits expression of Notch1 and
Notch3 themselves, and, either by direct repression or as a result of reduced Notch
expression, it keeps T-lineage genes silent. In the absence of LRF, T-cell specification genes
are spontaneously activated in bone marrow progenitors79.
Thus, even before Notch signalling, T-cell precursor competence is defined by expression of
PU.1, Ikaros, RUNX-CBFβ complexes, and readily mobilized E proteins. In each subset,
LRF may also be important for establishing the threshold that the Notch signals must
overcome in order to initiate the T-cell programme in those cells.
ETP to DN2: delay vs. progression
ETPs are clearly excellent T-cell precursors, but they present some paradoxes. ETPs
profoundly depend on Notch-driven transcription for their maintenance45,80,81, and they
already strongly express the Notch-promoted genes Hes1, Gata3, and Tcf7 at levels well
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above those of prethymic progenitors53,80. However, unlike cells responding to Notch in
vitro, adult murine ETPs delay many days (~10 days) and many cell cycles before activating
DN2-stage Notch target genes8. Although some ETPs already have DJβ TCR gene
rearrangements25, their expression of RAG recombinases is barely detectable (Fig. 2a,c).
The length of time spent proliferating in the ETP stage is also variable and subject to
regulation: it is much shorter for fetal thymocytes, and the size of the ETP pool is adjusted
dynamically based on niche availability and homeostatic feedback82,83. So, even when the
requirements are met for initiating T-lineage development in response to Notch signals,
presumably including MYB, RUNX–CBFβ, Ikaros, and E proteins, there must be additional
regulatory inputs that control whether precursors will stay in a “holding pattern” for another
cell cycle as ETPs or “graduate” onward as DN2 cells (Fig. 1; Fig. 4a).
Two regulators specifically needed to generate DN2 cells are TCF1 and the transcriptional
repressor GFI184,85 (Fig. 4b). It is not clear yet whether GFI1 controls the ETP to DN2
transition itself or helps to make competent ETPs, and there is little increase in GFI1 from
ETPs to DN2 (Fig. 2b). TCF1 is an attractive candidate for a rate-limiting positive regulator
of the DN2 transition because of its increasing, Notch-dependent expression pattern34,53 and
because many T-lineage differentiation genes, including Cd3g and Cd3e, have predicted
TCF1 binding sites in their promoter regions (H. T. Petrie and M. Fallahi, personal
communication). Analogously to the Notch pathway, microenvironmental WNT signalling
can convert TCF1 to an activator through interaction with β-catenin86,87. However, indirect
evidence suggests that WNT signalling may already be occurring in most ETPs87,88.
Additional regulatory inputs that delay ETPs from proceeding to the DN2 stage must exist in
the adult thymus, and notably, at least three microenvironmental signalling systems are
implicated.
Progression of ETPs to the DN2 stage can be held back by the action of certain members of
the bone morphogenetic protein (BMP) and fibroblast growth factor (FGF) families89–91,
which appear to promote ETP self-renewal. The effects of these environmental signals seem
to be counteracted by activation of the hedgehog signalling pathway, working through GLI2,
which appears to enhance the generation of DN2 cells65 (Fig. 4a).
Notch itself may also play a two-sided role. There is a natural damper of Notch-dependent
transcription, MSX2-interacting protein (MINT)92, which is normally expressed abundantly
in ETPs, with levels declining into DN3 and after β-selection. MINT-deficiency should
increase Notch-mediated transcriptional activation, and this might be expected to enhance T-
cell specification. The observed phenotype, however, is the opposite: MINT mutants
accumulate ETPs with reduced transit to the DN2 stage. Is too much Notch signalling a
stalling factor that keeps cells in the ETP stage? Crosstalk with Hedgehog, BMP, or WNT
pathway mediators could occur. Another pathway may be through direct Notch target gene
NRARP, a cytoplasmic ankyrin-repeat protein that can act as a potent feedback inhibitor of
Notch signalling, targeting a different aspect of the Notch signalling pathway than MINT93.
When MINT is deleted, ETPs accumulate much higher levels of RNA encoding NRARP
than normal ETPs, losing one kind of Notch modulator but gaining another92,93, and this
could also bias MINT-deficient ETPs to expand without progressing. In either case, the role
of MINT shows that a Notch-dependent gene regulatory network, not simply Notch
signalling alone, may channel cells differentially between ETP self-renewal and transit to
the DN2 stage.
Lineage plasticity in the early T-cell precursor stages
Notch signalling plays an important role in the “negotiation” over cell fate throughout the
ETP stage and into the DN2 stage. Although all but the earliest CCR9+ FLT3+ immigrants
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have lost B cell potential, at least some of these cells retain myeloid, DC, NK-cell, and even
(rarely) mast-cell50 potential, revealed under permissive environmental conditions. This
lineage instability reflects the mixture of T-lineage and persisting stem-cell transcription
factors in ETP and DN2 cells (reviewed in refs. 51,58,94) (Fig. 2). “Non-T factors” present in
ETP and DN2a cells, such as ID2, SCL, C/EBPα, GATA2, and PU.1, are likely to play
direct roles in maintaining non-T-cell developmental options. C/EBPα and PU.1 are each
sufficient to impose a myeloid or DC programme on T-lineage precursors, if expressed
ectopically after their endogenous expression is normally turned off52,95–97, and PU.1 is
required for normal DC development from thymocytes97. ID2 and SCL work as modulators
or antagonists of E-protein activity, and this antagonism is crucial for ID2 to promote NK-
cell development98,99.
Not only do these non-T-cell factors promote specific alternative pathways, but they also
make the regulatory state of ETPs and DN2 cells intrinsically unstable. In these stages, even
GATA3, a transcription factor of the T-lineage core group, can drive alternative fates, only
supporting the early stages of T-cell development within a highly limited dose-response
range50. Increased concentrations of GATA3 drive ETPs and DN2 cells into the mast-cell
lineage50, although GATA3 is clearly and repeatedly essential for T-cell development at
multiple stages59,61. Early T-cell precursors are also sensitive to cytokine stimulation of
ectopic receptors, such as the GM-CSF receptor or the IL-2Rβ–γc complex: cytokine
signalling of these receptors is sufficient to activate a myeloid programme in ETPs or DN2
cells43,100. This can occur by triggering upregulation of C/EBPα and/or PU.1 activity101,102,
or by precocious activation of protein kinase C or RAS, mediators normally activated by
TCR signalling but which strongly enhance lineage diversion if PU.1 is present96. The cells
only stabilize their T-cell identity when these non-T factors are finally silenced.
Uncommitted precursors are probably restrained from these developmental alternatives in
vivo by interaction with intrathymic Notch ligands19,50,52,95. Notch signalling inhibits,
though it does not eliminate, NK-cell differentiation potential47,103,104. Although Notch
signalling does not repress PU.1 directly, it does protect newly induced T-lineage
differentiation and regulatory genes from repression in the presence of high concentrations
of PU.152, thus tilting the balance of a bistable regulatory switch toward T-lymphoid and
against myeloid fate58. Through a different pathway, Notch–Delta interactions also restrain
GATA3-overexpressing cells from diversion to the mast-cell lineage50. The biochemical
mechanisms remain to be determined, but in each case, Notch signalling acts to preserve
access to the T-lineage programme without extinguishing regulators for other developmental
options.
Effects on E proteins may be at the crux of the balance between T-cell and non-T-cell
developmental alternatives58 for ETPs and DN2 cells. Both the NK-cell pathway and the
myeloid and DC alternatives to T-cell development involve repressing or neutralizing E
proteins. When either PU.1 or C/EBPα is re-introduced to committed DN3 cells to divert
them to a myeloid or DC fate, one of their earliest effects is to inhibit net E-protein
activity52,95. HEBalt is a particularly sensitive repression target52,96. Correspondingly,
Notch signalling maintains HEBalt and inhibits upregulation of Id2 in response to PU.152.
The different roles of various E protein heterodimers make them challenging to study, but
these results suggest that E-protein activity may be pivotal for the lineage fidelity of early T-
cell precursors.
Why is broad lineage plasticity retained so long by early T-cell precursors? One possible
answer is that until TCR gene rearrangement, pro-T cells regulate their proliferation through
mechanisms shared with multipotent haematopoietic progenitors, and that the non-T factors
are part of this mechanism. ID2 is directly involved in cell-cycle progression in many cell
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types105, and it may be indispensable to maintain proliferation in the presence of high levels
of E-protein activity until another, lymphoid-specific ID factor, ID3, becomes induced (Fig.
2). Both PU.1 and SCL are important for maintenance of multipotent haematopoietic
progenitors75,76,106,107, possibly through target genes such as cKIT108,109 and the cell-cycle
activator CDK6110. Thus, throughout the pro-T cell stages, the T-cell-specific gene
expression programme may gradually be assembled onto the “armature” of a proliferating
multipotent progenitor state. If so, this “armature” can apparently be removed only when
assembly is complete.
T-lineage commitment: transit to the DN3 stage
After the plasticity of the ETP and DN2 stages, the DN3 stage marks a break. Not only do
most T-cell genes become fully activated, but also, the cells lose all non-T developmental
options and stop proliferating. The transition from proliferative expansion to cell-cycle
arrest enables the TCR gene rearrangement process to be fully activated. During in vitro
differentiation, the DN2 population often expands abnormally at the expense of DN3
generation, implying that this transition also requires specific regulation72,111.
A phenotypically normal DN2 to DN3 transition depends on RUNX1–CBFβ complexes, and
RUNX1–CBFβ as well as MYB, GATA3, and BCL11B are needed for full TCRβ gene
rearrangement and competence to undergo β-selection77,111–116 (Fig. 4b). Cis-regulatory
analysis of TCR and RAG1/2 indicates specific sites where most of these factors can be
implicated in direct regulation (rev. in ref.2). Although none of these transcription factors
increases much in expression from DN2 to DN3 (Fig. 2b,c), their functions are very likely
modified by the induction of new participants. Of particular interest, ETS1 and ETS2 are
sharply upregulated at this point (Fig. 2b,c). ETS1 collaborates with Runx in TCR gene
expression and may enhance Runx factor activity profoundly67. Another ETS factor, SPIB,
may contribute to checkpoint arrest97. PU.1 specifically inhibits ETS1, ETS2, and SPIB
expression in thymocytes52, and so the timing of their induction may await the
downregulation of PU.1.
As in all the previous stages, Notch and E proteins play major roles too. The DN3 stage is
the peak period for expression of Notch/RBPJ and E protein target genes such as Deltex1,
Rag1, Hes1, and Ptcra (Fig. 2). Murine DN3a pro-T cells, prior to β- or γδ-selection, are
acutely dependent on Notch signalling to maintain viability through phosphoinositide 3-
kinase (PI3K) pathway signals and activation of the proto-oncogene cMyc117–119. E2A and
HEB activity are crucial not only for TCR gene rearrangement62, but also for the ability to
undergo normal β-selection even when a rearranged TCR transgene is supplied120. E2A and
HEB together are particularly implicated in maintaining the DN3-stage proliferative
arrest121: in part they activate expression of growth inhibitory factors, such as suppressor of
cytokine signalling (SOCS)1 and SOCS3 proteins, which uncouple growth-factor receptors
like IL-7R from their signalling pathways; and in part they directly inhibit cell-cycle-
activating genes such as Cdk6122. This cell-cycle-arresting role of E proteins is important for
checkpoint control (Fig. 4b). When E2A is mutated, not only is TCR gene rearrangement
defective, but also the penalty for failure is removed, and cells can proceed abnormally
through the β-selection checkpoint123. Such E2A-deficient unchecked cells are prone to
leukaemic transformation. However, note that if E2A and HEB were to exercise this
function earlier, they would abort T-cell development, as is seen when these factors are
experimentally overexpressed64. Finally, there is new evidence that E proteins are also
responsible for making the DN2 to DN3 transition irreversible. Both E2A and HEB together
have been conditionally deleted in DN3 thymocytes, and the loss of these E proteins not
only prevents proliferative arrest at the DN3 stage but also enables DN3 cells to undergo
reverse differentiation, to return to a DN2-like phenotype121. A key question is now whether
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such removal of E-protein activity may also be sufficient to restore expression of the
progenitor-cell regulatory factors and broader developmental potentials of earlier states.
Directly or indirectly, the uniqueness of the DN3 state may depend on particularly high
doses of both Notch and E-protein activity. The peak-level Notch target gene expression
could reflect naturally decreased MINT expression in the DN3 cells92; or enhanced
responsiveness to Delta-family Notch ligands through increased expression of the modifier
Lunatic Fringe (Lfng)124; or migration into an intrathymic zone8 (subcapsular region, Fig. 1)
that presents an increasingly potent Notch ligand, DL4125. In parallel, although E-protein
(E2A and HEBcan) gene expression itself is relatively unchanged throughout development64
(Fig. 2b), the accumulation of E protein greatly increases at the DN3a stage126. Reduced
SCL and ID2 expression could be responsible, although surprisingly, ID3 expression
increases at this stage and might be expected to continue antagonizing E-protein activity34
(Fig. 2b,c). The high accumulation of HEBalt in DN3 cells may contribute, either as a highly
stabilizing partner for full-length E proteins or as an ID-interaction decoy64. Adjustments in
levels of Notch and E proteins can apparently compensate for each other78. Fetal murine
pro-T cells express surprisingly high levels of Id2 which should inhibit E protein activity,
but transcriptional evidence also suggests they experience unusually strong Notch activity
which may compensate34.
Commitment depends not only on irreversibility but also on repression, and the main
unresolved issue about the DN2 to DN3 transition is how the “non-T factors” become
silenced in the DN2 and DN3 stages. The sweeping downregulations of factors like PU.1
and SCL/TAL1 from high stem-cell levels53 are among the most profound regulatory
changes that occur during T-cell specification. However, very little is known yet about T-
lineage-promoting repression. Notch signalling induces expression of a repressor, HES1, but
this factor probably does not repress PU.1, as it is not required to block myeloid potential or
confer T-cell potential in fetal progenitors23. It may be more important that RUNX, MYB,
and TCF-1/LEF-1 factors, all expressed at peak levels in DN3 cells, also have the capacity
to act as repressors, especially in certain isoforms. In this context, the repressor activity of
BCL11B is also of particular interest. The key factors may be defined by their interaction
with the corepressor NCOR1 (nuclear receptor co-repressor 1), which is reportedly essential
to prepare cells for β-selection127. Cis-regulatory analysis of repression targets Scl/Tal1 and
Sfpi1 (PU.1) could “bait the trap” to identify repressors mediating commitment.
From “haematopoietic” to “immunological” T-cell development
From β-selection or γδ-selection onwards, multiple regulatory changes are triggered by TCR
signals, but T lineage identity is completely and stably established. The basic set of T-
lineage effector genes continues to be expressed as the cells diverge to αβ, γδ and other
specialized T-cell lineages (Fig. 2a), even though quite different combinations of
transcription factors are used in γδ and different subsets of αβ-lineage cells27,59,68,128 (Fig.
2b). Most importantly, neither the thymic microenvironment nor the DN3 transcription
factor set are needed to maintain the T-lymphoid identity of the cells. Notch signal-
dependent transcription becomes dispensable129, E-protein activity is at least reduced, and
many of the transcription factors that participated in the early T-cell precursor stages
decrease or disappear37,38 (Fig. 2b).
This means that the specification mechanisms that turned on T-cell genes probably work in a
ratchet-like fashion to make activation of genes like Cd3g and Cd3e virtually irreversible.
One way this could occur is by substituting the roles of the transcription factors that initiate
development with different members of the same transcription factor family that are
expressed stably in mature cells. For example, the ETS-family transcription factor GABPα
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can drive expression of IL-7Rα in PU.1-negative cells through the same cis-element that PU.
1 uses when it is present130. Another mechanism is probably the establishment of durable
epigenetic changes in the accessibility of T-cell and non-T-cell genes, which could make
continuing T-cell gene expression a default, no longer dependent on delicately titrated
regulatory balances. Such mechanisms are probably essential to explain the completion of
the specification process and may be even more important for establishing a strong barrier
against reactivation of the non-T-cell regulators that were expressed at earlier stages.
Concluding remarks
T-cell specification is a segmented process. The completion of T-lineage commitment is far
removed from the initial responses to Notch signalling, with distinct steps in between that
are sensitive to environmental influence. Ongoing requirements for Notch and E proteins
provide continuities throughout this process, but different sets of Notch and E protein target
genes are activated at each step. As discussed here, this is because each step is distinguished
by changes in other transcription factors and sensitivities to changing cytokines and other
signals encountered during migration through the thymus that create a constantly shifting
regulatory context. As suggested elsewhere7, some of the remarkable developmental
stability of T-cell identity after β-selection may be due to the completeness with which the
cells finally extinguish expression of the regulators for competing fates. The identity of the
critical silencing functions is another remaining mystery. It will now be important to
determine the exact mechanisms that control deployment of Notch/RBPJ, E proteins, and
other “core group” factors that seem to be present throughout, to activate precisely shifting
sets of T-lineage genes at each step.
BOX 1: Purification of early thymic subsets
A high level of cell-subset purity is particularly important to allow gene expression to be
analysed reproducibly and for the results to be correlated meaningfully with
developmental assays. Although the CD4−CD8− double negative (DN) early T-cell
subsets are usefully subdivided by the expression of CD25 and CD44, those parameters
alone are insufficient for rigorous purification of DN subsets without contaminating
cells6. In particular, the CD25−CD44+ so-called DN1 population is very heterogeneous
and only a minority of thymocytes with this phenotype are actually early T-cell
precursors25,131. In addition to unrelated haematopoietic cells, this population is often
contaminated with mature natural killer (NK) cells, NKT cells and γδ T cells. Such cells
often share high levels of CD44 expression with genuine T-cell precursors, and even
when depletion protocols designed to remove cells expressing the T-cell receptor (TCR)
and NK-cell markers as well as cells expressing CD4 and CD8, the low levels of
expression of mature cell-surface receptors on these cell types cause inefficient depletion.
Additional use of selection protocols based on surface expression of c-KIT allows for
more efficient purification of the potent T-lineage precursors6,25,131, and in this Review
we use the term ETP (early T-cell precursor)25 to refer to the c-KIT++ DN1 cells (Fig. 1,
Fig. 3). Likewise, evidence is accumulating that DN2 cells are not a homogenous
population. They can be subdivided by cell-surface expression levels of c-KIT into DN2a
and DN2b populations (Fig. 3), and recent data show that this distinction may correspond
to the loss of dendritic-cell potential33. DN3 cells can also be subdivided into those
before and immediately after β (or γδ)-selection (DN3a and DN3b, respectively) based on
size132 and CD27 expression27. These finer distinctions between sequential
developmental stages give a sharper resolution to the changing gene regulatory events
that take place during the course of T-cell differentiation.
BOX 2: Same transcription factor protein, different target gene effects
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Several general principles make it possible for the same transcription factor protein to
have effects on widely different sets of target genes at different stages in a developmental
process. First, the effect of a particular transcriptional regulator depends on its dose, due
to DNA-binding biophysics. Transcription factors at high concentration can bind to a
wider range of DNA sites than they can at low concentration. Second, the effect of any
essential regulatory factor depends on combinatorial interaction with other factors and
signalling pathways. These affect the binding of the essential factor to particular cis-
regulatory elements, sometimes in an all-or-nothing fashion, and may change the net
effect from activation to repression or vice versa. Finally, the effect also depends on the
gene network within which the factor of interest operates. Among the target genes
activated by a factor can be genes encoding inhibitors of the initial regulator itself. Such
feedback negative regulation can make a significant difference between the impact of a
factor when continuously expressed and the impact of the same factor when activated in a
discontinuous or oscillating manner. Thus, it is likely to be significant that several Notch
target genes expressed in pro-T cells encode inhibitors of Notch signalling itself93,133.
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Figure 1. Stages in early T-cell development
Top panel: Path of T-cell precursors through the thymus during development. A major
pathway for adult murine thymocyte development is depicted, with cells shown from the
point of entry into the thymus at the cortico–medullary junction through their migration to
the outer rim of the cortex during the progression toward commitment, on the left-hand path.
Early T-cell precursors (ETP), double negative (DN) 2 subsets, DN3 subsets, and DN4 cells
are defined as described in Table 1. In the adult thymus, the immigrants initially enter the
thymus through vessels near the cortical-medullary junction, and migrate outward through
the thymus as shown as they pass through the indicated stages8. Note that at any given cell
cycle, the ETPs appear to have the options either to continue their expansion, with minimal
differentiation, in the cortical-medullary junction region or to differentiate into DN2 cells
(presumably, DN2a cells as shown) and begin their migration outward through the cortex.
For β-selection, they are situated in the extreme outer portion of the thymus (subscapsular
Rothenberg et al. Page 20
Nat Rev Immunol. Author manuscript; available in PMC 2011 July 7.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
zone). The reversal of migration for later stages of thymocyte development is shown on the
right-hand path. Broken arrows depict alternative developmental pathways that are still open
to ETP and different subsets of DN2 cells that are likely to correspond to DN2a and DN2b
cells.
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Figure 2. Expression levels of differentiation and regulatory genes in early T-cell development
A comprehensive set of expression patterns is shown for 39 differentiation and regulatory
genes in subsets of adult murine thymocytes. To summarize expression patterns of these
genes for valid inter-gene comparisons, quantitative real-time RT-PCR results are collected
here from a fixed set of 2–4 biological replicates of each of the populations indicated. All
measurements were carried out as previously described27,34,35,38,50,52,53,68,96, and similar
results are reported by others33,36,37,133. The amounts of mRNA expressed are normalized to
β-actin at each developmental stage and the values depicted as “heat maps”, using a color
code to indicate relative levels on a logarithmic scale as previously described53. Although
small differences in gene expression levels can be meaningful, this method provides the
dynamic range to depict changes of both smaller and larger magnitude. Briefly, the central
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value (“mid”) for each gene is the geometric mean of the maximum and minimum
expression levels for that gene in the sample series, and the threefold range around this value
is coded green. In (a) and (b), the mid value is for all cell subsets shown; in (c) it is the mid
value for ETP, DN2a, DN2b, and DN3 cells only. The overall range of expression is then
separated into discontinuous “bins” in which each shade redder represents a 3-fold increase
in mRNA, while each shade bluer represents a 3-fold decrease. This analysis permits
comparison between patterns of expression but does not indicate absolute RNA
accumulations: poorly-expressed genes can give variability in the lower range as the central
value itself is close to the detection threshold. Red stars indicate an essential member of the
regulatory “core group”. Orange stars indicate partially redundant members of the “core
group”. Blue stars mark PU.1, an early core group member that later switches to become an
antagonist of T-cell development.
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Figure 3. Phenotypic markers for the transitions through specification and commitment
Left hand panels: flow cytometric profiles of CD4−CD8− double negative (DN) thymocytes
from adult mice, gated for viability and absence of mature-cell lineage markers, using CD44
and c-KIT (top panel) and CD44 and CD25 (lower panel). Conventional DN1, DN2, DN3,
and DN4 quadrants are marked on the lower left plot.
Upper right: profiles of c-KIT and CD25 expression in CD44+c-KIT+ DN thymocytes,
distinguishing Early T-cell Precursors (ETP), DN2a, and DN2b subsets.
Lower right panel: location of the ETP, DN2a, DN2b, and DN3 cells within the CD44 and
CD25 expression distribution of the whole DN population.
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Figure 4. Genetic evidence for temporal roles of regulatory factors in early T-cell development
The figure summarizes times in early T-cell development when the indicated genes are
essential. Data are from germline and conditional knockout studies, with additional details
from in vitro differentiation assays2,29,54,58–62,77,84,85,111–115. Note the repeated inputs from
Notch signalling and E proteins at successive stages, and the importance of MYB, RUNX--
CBFβ, and GATA3 both in the earliest stages and in the functions of double negative (DN)3
cells. DN2 stages have not yet been subdivided into DN2a and DN2b in any of the literature
used as sources, so this distinction has not been included. Blue text and arrows: factors
promoting T-cell differentiation at a particular transition (the order of arrows shown at any
one transition does not necessarily indicate the order of transcription factor activity). Purple
text: factors promoting alternatives to T-cell development. Panel (a): stages from
haematopoietic stem cell (HSC) to the ETP-DN2 choice point. The stages at which cells
become primed to respond to Notch signals by undergoing T-lineage specification are
shown. Evidence for a possible early role of E protein is noted but its timing is uncertain.
Prec. = any relevant prethymic precursor population (not specifically defined). Diamond: a
choice point, discussed in the text, at which ETP cells may undergo further self-renewal or
else proceed to the DN2 stages; however, both choices can enhance T-cell development
although with different kinetics. Panel (b): recursive roles of E proteins and Notch/Delta
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(Notch/DL) signalling at stages from the ETP stage through β-selection. Developmental
options still open at the DN2 stage(s), and the potential reversal of the DN2 to DN3
transition, are alternatives shown by broken arrows. The broken gray line depicts the β-
selection checkpoint, that is the boundary between TCR-independent developmental stages
on the left and the later TCR-dependent developmental stages in the shaded zone on the
right. The later developmental changes from DN4 to ISP (immature single positive) to DP
are not shown as discrete transitions. Below scheme: grey triangles show approximate
timing of major increases (upward-pointing) or decreases (downward-pointing) in the
expression of other indicated transcription factor genes (cf. Fig. 2) as discussed in the text.
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